These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32157924)

  • 1. Galectin-3 is a potential biomarker to insulin resistance and obesity in women with polycystic ovary syndrome.
    Alves MT; de Souza IDP; Ferreira CN; Cândido AL; Bizzi MF; Oliveira FR; Reis FM; Gomes KB
    Gynecol Endocrinol; 2020 Sep; 36(9):760-763. PubMed ID: 32157924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.
    Hahn S; Backhaus M; Broecker-Preuss M; Tan S; Dietz T; Kimmig R; Schmidt M; Mann K; Janssen OE
    Eur J Endocrinol; 2007 Aug; 157(2):201-7. PubMed ID: 17656599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum galectin-3 levels in women with PCOS.
    Yilmaz H; Celik HT; Ozdemir O; Kalkan D; Namuslu M; Abusoglu S; Atalay CR; Yigitoglu R
    J Endocrinol Invest; 2014 Feb; 37(2):181-7. PubMed ID: 24497217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.
    Kort DH; Kostolias A; Sullivan C; Lobo RA
    Gynecol Endocrinol; 2015 Feb; 31(2):152-5. PubMed ID: 25295622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.
    Kucukaydın Z; Duran C; Basaran M; Camlica F; Erdem SS; Basaran A; Kutlu O; Burnik FS; Elmas H; Gonen MS
    J Endocrinol Invest; 2016 Oct; 39(10):1139-48. PubMed ID: 27300033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
    Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
    Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of sestrin 2 and tribbles homolog 3 levels in obese and nonobese women with polycystic ovary syndrome.
    Çatal A; Kovalak EE
    Turk J Med Sci; 2023; 53(6):1697-1703. PubMed ID: 38813505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive correlation of serum leptin with estradiol levels in patients with polycystic ovary syndrome.
    Mendonça HC; Montenegro RM; Foss MC; Silva de Sá MF; Ferriani RA
    Braz J Med Biol Res; 2004 May; 37(5):729-36. PubMed ID: 15107936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters.
    Chapman IM; Wittert GA; Norman RJ
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):175-81. PubMed ID: 9135699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin resistance and oxidative marker in women with PCOS.
    Bannigida DM; Nayak BS; Vijayaraghavan R
    Arch Physiol Biochem; 2020 May; 126(2):183-186. PubMed ID: 30450993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
    Song DK; Hong YS; Sung YA; Lee H
    PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome.
    Ding L; Gao F; Zhang M; Yan W; Tang R; Zhang C; Chen ZJ
    Fertil Steril; 2016 May; 105(5):1330-1337.e3. PubMed ID: 26868993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Madej P; Wdowczyk M; Owczarek A; Chudek J
    Eur J Endocrinol; 2015 Feb; 172(2):173-9. PubMed ID: 25411238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.